Lessons from ticlopidine-induced liver injury

Hepatology Research

Volumn 33, Issue 3, 2005, Pages 193-194

  Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; ISONIAZID; MEVINOLIN; TICLOPIDINE; TIOPRONIN;

ACUTE HEART INFARCTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGINA PECTORIS; BLOOD ANALYSIS; CHOLESTASIS; DRUG METABOLISM; DRUG OXIDATION; DRUG PROTEIN BINDING; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HEALTH SURVEY; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; LIVER METABOLISM; LIVER TOXICITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFORMATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK REDUCTION;

EID: 29144431665     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.06.009     Document Type: Editorial

References (22)

1. P.C. Kam C.M. Nethery The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments Anaesthesia 58 2003 28-35
2. K. Yoneda R. Iwamura H. Kishi et al Identification of the active metabolite of ticlopidine from rat in vitro metabolites Br J Pharmacol 142 2004 551-557
3. H. Takikawa Y. Takamori T. Kumagi et al. Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting Hepatol Res 27 2003 192-195
4. M. Watanabe A. Shibuya Validity study of a new diagnostic scale for drug-induced liver injury in Japan - comparison with two previous scales Hepatol Res 30 2004 148-154
5. H. Takikawa M. Onji A proposal of the diagnostic scale of drug induced liver injury Hepatol Res 32 4 2005 250-251
6. Y. Tameda Y. Adachi A. Watanabe National survey of drug induced liver injury In: A. Watanabe K. Higuchi editors Saishin Kanzobyogaku 2001 Shinko-Igaku Shuppan Tokyo 50-61
7. J.E. Naschitz R. Khamessi N. Elias D. Yeshurun Ticlopidine-induced prolonged cholestasis J Toxicol Clin Toxicol 33 1995 379-380
8. L.J. Cassidy B.G. Schuster L.S. Halparin Probable ticlopidine-induced cholestatic hepatitis Ann Pharmacother 29 1995 30-32
9. P. Amaro A. Nunes F. Macoas et al. Ticlopidine-induced prolonged cholestasis: A case report Eur J Gastroenterol Hepatol 11 1999 673-676
10. C.J. Kubin O. Sherman K.B. Hussain L. Feinman Delayed-onset ticlopidine-induced cholestatic jaundice Pharmacotherapy 19 1999 1006-1010
11. Y.D. Skurnik A. Tcherniak K. Edlan Z. Sthoeger Ticlopidine-induced cholestatic hepatitis Ann Pharmacother 37 2003 371-375
12. N. Leone C. Giordanino Baronio et al. Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteiroids: A case report Hepatol Res 28 2004 109-112
13. H. Tsutsumi Y. Terano C. Sakagami et al. Drug-specific T cells derived from patients with drug-induced allergic hepatitis J Immunol 149 1992 706-716
14. M. Kurosaki H. Takagi M. Mori HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin Digest Dis Sci 45 2000 1103-1108
15. A. Berson E. Freneaux D. Larrey et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis J Hepatol 20 1994 336-342
16. Y. Ikeda T. Tsukada T. Harada M. Hirano Panaldine. Information for User 2005 Daiichi Pharmaceutical Co. Tokyo [in Japanese]
17. M. Mizushima N. Iwata T. Fujimoto K. Ishikawa K. Fujimura Patient characteristics in ticlopidine hydrochloride-induced liver injury: Case control study Hepatol Res 33 3 2005 234-240
18. N.T. Ha-Duong S. Dijols A.C. Macherey et al. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19 Biochemistry 40 2001 12112-12122
19. T. Richter T.E. Murdter G. Heinkele et al. Potent mechanism-based inhibtion of human CYP2B6 by clopidogrel and ticlopidine J Pharmacol Exp Ther 208 2004 189-197
20. Endo G, Kozuma K, Watanabe S, et al. The incidence and the time course of adverse effects of ticlopidine after percutaneous coronary intervention. Jpn J Intervent Cardiol, in press [in Japanese].
21. K. Takeda N. Mizokawa K. Ito et al Drug induced liver injury by ticlopidine Proceeding of the Ninth Annual Meeting of Japanese Society of Hospital Pharmacy 1999 151 [in Japanese]
22. W.C. Maddrey Drug-induced hepatotoxicity J Clin Gastroenterol 39 2005 S83-S89